Tryptophan and triptan effectiveness in migraine
Treatments studied
Part of Brain & nervous system clinical trials.
This study looks at how tryptophan (a natural amino acid) affects how well triptans work for migraines. You may be able to join if you've taken triptans before, whether they helped or not.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You have been diagnosed with migraine by a doctor.
- You have taken triptans before, and your doctor knows how well they worked for you.
- You are a man, or a woman who is not pregnant or breastfeeding.
- You are affiliated with a social security system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two first-line migraine prevention medications in primary care. It's designed for adults who have frequent migraines (4 to 14 days per month) and have not yet tried a preventive medication.
This study compares three common migraine prevention medications to see which works best. You might be able to join if you have migraines at least 4 days a month and haven't taken these specific drugs before.
This trial tests a new oral medication called elismetrep (K-304) for quickly stopping migraine pain and other symptoms. If you have regular migraines, this could offer a new option that works fast when a migraine starts.
This study looks at how psilocybin affects the brain in people with migraines and in healthy volunteers. The goal is to understand why it may help with headache disorders.
This study tests how well the combination of sumatriptan and naproxen (a specific migraine treatment) works in real life for people with migraines. It looks at how effective it is and how it affects your quality of life.
This trial tests if eptinezumab can stop a migraine attack that is already happening. It may help people who get migraines often and are already part of the TACHIS study.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.